Albumin versus plasma for swelling in children with kidney disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial compares two treatments (albumin and fresh frozen plasma) to see which is better for reducing swelling in children with nephrotic syndrome when water pills alone don't work. The goal is to find a safer and more effective way to manage this difficult-to-treat swelling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 2 and 12 years old.
- Your child must have nephrotic syndrome (a kidney condition causing protein in urine and swelling) that is idiopathic, meaning the cause is unknown.
- Your child's swelling (edema) must not improve with water pills (diuretics).
- Your child must not have serious heart, liver, kidney, or infection problems, or be unstable.
- Your child must not have had a recent blood exchange transfusion, and you must agree to attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-invasive approach to diagnose idiopathic nephrotic syndrome, which affects the kidneys. It may help patients avoid a kidney biopsy.
This study tests whether giving albumin (a protein) along with water pills helps reduce leg swelling in people with cirrhosis and ascites. It may be an option if your leg swelling hasn't improved with standard diuretics alone.
This study looks at children newly diagnosed with nephrotic syndrome to understand how genes and proteins in the blood might predict the disease's course and response to treatment. By collecting samples, researchers hope to find markers that could guide better, more personalized care for future patients.
This study tests a new way to give fluids during sepsis in children to improve blood flow and recovery. It compares a standard saltwater solution to a plasma-based solution to see which works better.
This study uses interviews to understand how swelling from nephrotic syndrome affects daily life for children and their caregivers. It may help researchers design better care by capturing the patient and parent perspective.
This trial studies two ways of giving albumin (a protein given through an IV) to people with cirrhosis who also have a sudden kidney injury from sepsis. The goal is to see which method—tailored to each patient or a fixed dose—is safer and works better for kidney recovery.
Hear when a new Idiopathic Nephrotic Syndrome (INS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.